Choppie is a 10-year-old neutered male Border Collie with severe naturally occurring osteoarthritis in the right hip, moderate bilateral elbow dysplasia, and spondylosis. Despite chronic multimodal pain management—including pharmacological therapy, nutraceutical support, and laser treatment—Choppie exhibited significant mobility impairment. He was unable to navigate stairs and struggled to rise from a lying position.
Due to limited response to conventional therapies, Choppie was enrolled in the VetREnew stem cell treatment program.
At 12 weeks post-treatment, Choppie showed marked clinical improvement. His ability to rise and manage stairs returned, and overall mobility and comfort were noticeably enhanced. No adverse events were observed.
This case illustrates the potential efficacy of VetREnew stem cell therapy in managing advanced osteoarthritis and spinal conditions in senior canine patients refractory to standard care.